NCT05335993 2026-04-03A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.CanariaBio Inc.Phase 2 Active not recruiting10 enrolled